I think you provide great info but this is wrong. Yes, the generics filed for ANDA and notified AMRN of it in which they filed suit. The court ruled that generics could have a use per the label that were "non-infringing" and therefore could have filed finalized the ANDA application then.
If you are saying this will not be overturned then you might as well dump the stock now.
It's not that hard, the appeal listed 3 items, one of which was the summary judgement and the only thing in that ruling that was in the generics favor was that. On another note, you have gone out of your way to incorrectly correct me several times. Do you desire to be the AMRN ihub alphadog or something? Lol
News 
Market Data 
Discover 
